Patent · US Active

Antibody specifically binding to ANG2 and use thereof

US9580497B2 · kind B2 · utility

0Cited by
4References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 2015
Grant dateFeb 28, 2017
Priority date
Expiry dateJan 27, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An Ang2 specific antibody, a method of preventing and/or treating a disease related to the activation and/or overproduction (overexpression) of Ang2 by administering the antibody to a subject, and a method of screening a candidate substance for diagnosing, preventing, or treating a disease related to activation or overproduction of Ang2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.